This announcement is a separate document:
康方生物-B：持續關連交易 派安普利單抗獨家銷售協議的 進一步資料
AKESO, INC. - B: CONTINUING CONNECTED TRANSACTIONS FURTHER INFORMATION IN RELATION TO EXCLUSIVE SALES AGREEMENT OF PENPULIMAB MONOCLONAL ANTIBODY
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.